PJ Kee

PJ Kee

PJ Kee is an Editor and Founder of the Trade Secret Insider and a member of Jones Walker’s Trade Secret and Non-Compete Team. He regularly litigates cases involving trade secret theft, non-competes, computer fraud, conspiracies, and unfair competition, and counsels clients on strategies to protect their trade secrets. Mr. Kee also represents clients in criminal proceedings and litigates complex commercial and employment matters involving various breach-of-contract claims, business torts, invasion of privacy claims, defamation, and wage and hour disputes. He can be reached at pkee@joneswalker.com or 504.582.8230.

 

Subscribe to all posts by PJ Kee

Trade Secret Theft Accounts For 1-3% of US GDP—Trade Secret Audits A Must

By PJ Kee on Posted in Data Protection, Trade Secret, Trade Secret Audit
PricewaterhouseCoopers LLP (PwC) and the Center for Responsible Enterprise and Trade (CREATe.org) collaborated to access the economic impact of trade secret theft. Their recently published Report estimates that trade secret theft accounts for nearly 1-3% of the US GDP. This impact highlights that companies should focus on tightening internal safeguards to protect trade secrets information. The Report offers a … Continue Reading

Texas Court Dissolves Injunction Vaguely Defining “Confidential Information”

By PJ Kee on Posted in Confidential Information, Data Protection, Injunction
An employer in Texas did nearly everything right to protect its stolen trade secrets—except adequately specify what the injunction restrained the employee from doing.  The opinion in Lasser v. Amistco Separation Products Inc., No. 01-13-00690 (Tex. App.—Houston Feb. 6, 2014), highlights the need for clearly defining restraints in any injunctive relief sought. Amistco Separation Products, … Continue Reading

FDA Spy Games: Employee Monitoring Requires Legal Advice

By PJ Kee on Posted in Confidential Information, Employee Monitoring, Trade Secret
The Office of Inspector General and a joint staff for two ranking Republican lawmakers recently issued critical reports on the FDA’s 2010-2011 employee monitoring for trade-secret leaks (see OIG and Joint Staff). They criticize the FDA for essentially “spying” on its employees without first assessing whether the computer monitoring may violate federal wiretapping laws and … Continue Reading
LexBlog